These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24569065)

  • 1. Heparin-induced thrombocytopenia and the health economic analysis of argatroban.
    Coventry DA; Webster NR
    Br J Anaesth; 2014 Jun; 112(6):964-7. PubMed ID: 24569065
    [No Abstract]   [Full Text] [Related]  

  • 2. The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia: the effect of early versus delayed treatment.
    Arnold RJ; Kim R; Tang B
    Cardiol Rev; 2006; 14(1):7-13. PubMed ID: 16371760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Argatroban treatment of heparin-induced immune-mediated thrombocytopenia].
    Nielsen JD; Heslet L
    Ugeskr Laeger; 2009 Feb; 171(8):610-1. PubMed ID: 19284906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.
    Webb DP; Warhoover MT; Eagle SS; Greelish JP; Zhao DX; Byrne JG
    J Extra Corpor Technol; 2008 Jun; 40(2):130-4. PubMed ID: 18705550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heparin-induced thrombocytopenia].
    Koide M; Matsuo T
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):307-10. PubMed ID: 9833497
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Hursting MJ
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argatroban for treatment of heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 2001 Feb; 43(1097):11-2. PubMed ID: 11177224
    [No Abstract]   [Full Text] [Related]  

  • 8. Argatroban therapy in women with heparin-induced thrombocytopenia.
    Jang IK; Baron SJ; Hursting MJ; Anglade E
    J Womens Health (Larchmt); 2007; 16(6):895-901. PubMed ID: 17678460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 10. A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT).
    Makhija K; Chapman K; Prasad R
    Pathology; 2021 Oct; 53(6):800-802. PubMed ID: 33610318
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary embolism and heparin-induced thrombocytopenia successfully treated with tissue plasminogen activator and argatroban.
    Hourmouzis Z; Bhalla MC; Frey JA; Jwayyed S
    Am J Emerg Med; 2015 May; 33(5):739.e5-6. PubMed ID: 25497698
    [No Abstract]   [Full Text] [Related]  

  • 12. Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy.
    LaMonte MP; Brown PM; Hursting MJ
    Crit Care Med; 2004 Apr; 32(4):976-80. PubMed ID: 15071388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
    Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with argatroban in one haemodialysed patient with a heparin-induced thrombocytopenia and thrombotic complications.
    Alatri A; Foramitti M; Paoletti O; Zimmermann A; Testa S
    Intern Emerg Med; 2010 Aug; 5(4):359-60. PubMed ID: 20177820
    [No Abstract]   [Full Text] [Related]  

  • 15. Argatroban in Thrombocytopenic Patients Sensitized to Circulating Protamine-Heparin Complexes.
    Wadowski PP; Felli A; Schiferer A; Panzer S; Opfermann P; Dworschak M; Holaubek C; Aliabadi-Zuckermann A; Steinlechner B
    J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1779-1783. PubMed ID: 28764988
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
    Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
    Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
    Levine RL; Hursting MJ; McCollum D
    Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia.
    Ekbatani A; Asaro LR; Malinow AM
    Int J Obstet Anesth; 2010 Jan; 19(1):82-7. PubMed ID: 19625181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin-induced thrombocytopenia].
    Christoffersen C; Lethagen S; Gøtze JP
    Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban approved for heparin-induced thrombocytopenia.
    Miller JL
    Am J Health Syst Pharm; 2000 Sep; 57(18):1650. PubMed ID: 11006790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.